JournalsHub
.online
Find My Journal
MP

Maud Plaschka

Université Claude Bernard Lyon 1 FR

ORCID 0000-0003-1137-7623
10
Publications
177
Citations
6
H-Index
5
i10-Index
10.0
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

ZEB1 transcription factor promotes immune escape in melanoma OA
Maud Plaschka, Valentin Benboubker, Maxime Grimont, Justine Berthet, Laurie Tonon +13 more
Journal for ImmunoTherapy of Cancer 2022
98
ZEB1 controls a lineage-specific transcriptional program essential for melanoma cell state transitions OA
Simon Durand, Yaqi Tang, Roxane M. Pommier, Valentin Benboubker, Maxime Grimont +8 more
Oncogene 2024
19
RASGRF2 gene fusions identified in a variety of melanocytic lesions with distinct morphological features
Aurélie Houlier, Daniel Pissaloux, Franck Tirode, Noémie Lopez Ramirez, Maud Plaschka +3 more
Pigment Cell & Melanoma Research 2021
16
NF-κB subunits RelA and c-Rel selectively control CD4+ T cell function in multiple sclerosis and cancer OA
Guilhem Lalle, Raphaëlle Lautraite, Khaled Bouherrou, Maud Plaschka, Aurora Pignata +22 more
The Journal of Experimental Medicine 2024
16
Efficacy and tolerability of neoadjuvant therapy with Talimogene laherparepvec in cutaneous basal cell carcinoma: a phase II trial (NeoBCC trial) OA
Julia Maria Ressler, Maud Plaschka, Rita Silmbrod, Victoria Bachmayr, Lisa E. Shaw +15 more
Nature Cancer 2025
11

Publications

10 total

Differential immune infiltrates in histomorphologic Wilms tumor regions identify prognostic macrophages

Lukas Watzke, F. Palmisani, M. Plaschka, F. Halbritter, Branka Radic-Sarikas - Molecular therapy. Oncology, 2026
Cited by 0 Semantic Scholar

Efficacy and tolerability of neoadjuvant therapy with Talimogene laherparepvec in cutaneous basal cell carcinoma: a phase II trial (NeoBCC trial) PDF

Julia Maria Ressler, Maud Plaschka, Rita Silmbrod, Victoria Bachmayr, Lisa E. Shaw et al. - Nature Cancer, 2025
Cited by 11 OpenAlex

ZEB1 transcription factor induces tumor cell PD-L1 expression in melanoma PDF

Chloé Wirbel, Simon Durand, Félix Boivin, Maud Plaschka, Valentin Benboubker et al. - Cancer Immunology Immunotherapy, 2025
Cited by 4 OpenAlex

ZEB1 controls a lineage-specific transcriptional program essential for melanoma cell state transitions PDF

Simon Durand, Yaqi Tang, Roxane M. Pommier, Valentin Benboubker, Maxime Grimont et al. - Oncogene, 2024
Cited by 19 OpenAlex

NF-κB subunits RelA and c-Rel selectively control CD4+ T cell function in multiple sclerosis and cancer PDF

Guilhem Lalle, Raphaëlle Lautraite, Khaled Bouherrou, Maud Plaschka, Aurora Pignata et al. - The Journal of Experimental Medicine, 2024
Cited by 16 OpenAlex

The NF-κB RelA transcription factor is not required for CD8+ T-cell function in acute viral infection and cancer PDF

Allison Voisin, Maud Plaschka, Marlène Perrin-Niquet, Julie Twardowski, Insaf Boutemine et al. - Frontiers in Immunology, 2024
Cited by 0 OpenAlex

An <i>in vivo</i> avian model of human melanoma to perform rapid and robust preclinical studies PDF

Loraine Jarrosson, Stéphane Dalle, Clélia Costechareyre, Yaqi Tang, Maxime Grimont et al. - EMBO Molecular Medicine, 2023
Cited by 9 OpenAlex

ZEB1 controls a lineage-specific transcriptional program essential for melanoma cell state transitions PDF

Simon Durand, Yaqi Tang, Roxane M. Pommier, Valentin Benboubker, Maxime Grimont et al. - bioRxiv (Cold Spring Harbor Laboratory), 2023
Cited by 4 OpenAlex

ZEB1 transcription factor promotes immune escape in melanoma PDF

Maud Plaschka, Valentin Benboubker, Maxime Grimont, Justine Berthet, Laurie Tonon et al. - Journal for ImmunoTherapy of Cancer, 2022
Cited by 98 OpenAlex

An <i>in vivo</i> avian model of human melanoma to perform rapid and robust preclinical studies PDF

Loraine Jarrosson, Stéphane Dalle, Clélia Costechareyre, Yaqi Tang, Maxime Grimont et al. - bioRxiv (Cold Spring Harbor Laboratory), 2022
Cited by 0 OpenAlex

Research Topics

Immunotherapy and Immune Responses (4) CAR-T cell therapy research (4) Melanoma and MAPK Pathways (4) Cancer Immunotherapy and Biomarkers (2) Cancer Cells and Metastasis (2)

Frequent Co-Authors

JU
Julie Caramel
8 joint publications
ST
Stéphane Dalle
7 joint publications
MA
Maxime Grimont
6 joint publications
AN
Anaïs Eberhardt
5 joint publications
VA
Valentin Benboubker
4 joint publications
YA
Yaqi Tang
4 joint publications

Affiliations

Université Claude Bernard Lyon 1
FR 2025 - 2021
Centre National de la Recherche Scientifique
FR 2025 - 2021
Inserm
FR 2025 - 2021
Centre Léon Bérard
FR 2025 - 2022
St Anna Children's Hospital
AT 2025 - 2024

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now